Gut-health, low glycemic, high protein bars

eCommerce with $308,000 in TTM revenue and $15,000 in revenue last month that manufactures a line of vegan nutrition bars around three core value propositions - plant-based protein, gut friendly fiber and low natural sugar. We are a real food bar that helps lower blood sugar by improving gut health. More life. More than just a snack. All of our bars are made from imperfect/upcycled ingredients from sustainable supply chains. Gluten Free, Dairy Free, Soy Free, Non-GMO Project Verified, Vegan, Made with Organic Ingredients. We have a line of 6 flavors, including 2 newly launched SKUs. ✅ $308,000 in TTM revenue ✅ $15,000 in revenue last month ✅ $5,000 in profit last month ✅ Competitors: Go Macro Bars, Nugo Bars, No Cow Bars

Category:
Ecommerce
Asking Price:
$150,000
Annual Revenue:
$208,842
Annual Profit:
$5,330

Growth Opportunity:

The US snack protein category and protein bar category is $3B. The snacking category is $11B. The business has been fully vetted and passed a proof of concept stage. We have strong customer loyalty with a high recurring customer retention rate. We are limited mainly by distribution. We are currently in just 45 stores out of a potential 514 stores throughout Whole Foods Market in the U.S. ($2M+ opportunity alone). In eCommerce, namely Amazon, we are also just getting started. Competitors are doing ~$4M annually on just Amazon. With our limited inventory on hand, we often sell out before we can restock resulting in missed revenue. Amazon FBA is a big missed opportunity. Of our FBA subscribers, average customer LTV is $240 through subscribe & save. This alone could be an easy revenue driver with limited effort invested into Amazon PPC. To-date we are not spending any money on advertising. We are on trend with all of the major attributes customers are looking for. Key trends right now include: prebiotics (Poppi and Olipop to name a few brands that are posed for big exits) and weight loss products like Ozempic that taught weight loss effects from GLP-1 hormone which can be naturally acheived through our product from balancing blood sugar. Past exits in the category have ranged from $15M - $600M with 3-5x EBITDA multiples. Brand has identified and begun implementing performance improvement initiatives to reduce burn, improve fulfillment and logistics (roughly 15% savings), and has negotiated favorable costing with contract manufacturing partners to improve margin by 10%. With these adjustments, the company will be a net positive operating income for 2024. Company is currently operating at break even with limited to no tradespend as a bootstrapped brand.